These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14600546)

  • 1. Physical activity and cancer prevention: animal-tumor models.
    Hoffman-Goetz L
    Med Sci Sports Exerc; 2003 Nov; 35(11):1828-33. PubMed ID: 14600546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counterpoint: From animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies.
    Bruce WR
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):401-4. PubMed ID: 12750233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical activity and cancer prevention--data from epidemiologic studies.
    Lee IM
    Med Sci Sports Exerc; 2003 Nov; 35(11):1823-7. PubMed ID: 14600545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products.
    Femia AP; Caderni G
    Planta Med; 2008 Oct; 74(13):1602-7. PubMed ID: 18604780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exercise intensity and duration on the induction of mammary carcinogenesis.
    Thompson HJ
    Cancer Res; 1994 Apr; 54(7 Suppl):1960s-1963s. PubMed ID: 8137320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of voluntary running wheel exercise on UVB-induced skin carcinogenesis in SKH-1 mice.
    Michna L; Wagner GC; Lou YR; Xie JG; Peng QY; Lin Y; Carlson K; Shih WJ; Conney AH; Lu YP
    Carcinogenesis; 2006 Oct; 27(10):2108-15. PubMed ID: 16699173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
    Mennuni C; Ugel S; Mori F; Cipriani B; Iezzi M; Pannellini T; Lazzaro D; Ciliberto G; La Monica N; Zanovello P; Bronte V; Scarselli E
    Cancer Res; 2008 Dec; 68(23):9865-74. PubMed ID: 19047167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing p53 biological functions through the use of genetically engineered mouse models.
    Attardi LD; Donehower LA
    Mutat Res; 2005 Aug; 576(1-2):4-21. PubMed ID: 16038709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel murine model for colon cancer: non-operative trans-anal rectal injection.
    Donigan M; Norcross LS; Aversa J; Colon J; Smith J; Madero-Visbal R; Li S; McCollum N; Ferrara A; Gallagher JT; Baker CH
    J Surg Res; 2009 Jun; 154(2):299-303. PubMed ID: 19101690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?
    Thalheimer A; Otto C; Bueter M; Illert B; Gattenlohner S; Gasser M; Fein M; Germer CT; Waaga-Gasser AM
    Eur Surg Res; 2009; 42(3):195-200. PubMed ID: 19270457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity as a negative modulator of estrogen-induced breast cancer.
    Coyle YM
    Cancer Causes Control; 2008 Dec; 19(10):1021-9. PubMed ID: 18543069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
    Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity and cancer prevention--mechanisms.
    Westerlind KC
    Med Sci Sports Exerc; 2003 Nov; 35(11):1834-40. PubMed ID: 14600547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.
    Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC
    Mutat Res; 2005 Aug; 576(1-2):80-92. PubMed ID: 15990122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical investigations of physical activity and cancer: a brief review and analysis.
    Thompson HJ
    Carcinogenesis; 2006 Oct; 27(10):1946-9. PubMed ID: 16885198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.